Product approved ..Shares soared

Discussion in 'Clovis Oncology' started by anonymous, Aug 23, 2016 at 4:31 PM.

Tags: Add Tags
  1. #1 anonymous, Aug 23, 2016 at 4:31 PM
    anonymous

    anonymous Guest

    With FDA expediting the approval of Clovis Oncology's new Ovarian Cancer drug. Stock price is expected to get back to the 100 dolars range. Like it used to be with the gowth of revenue.
     
    Quote

  2. #2 anonymous, Aug 27, 2016 at 1:34 PM
    anonymous

    anonymous Guest

    I totally agree. Some of the top pharma analysts have already given a price target of CLVS to 89 dollars by the end of this year. I just bough thousand at 24.00 I know it a money maker.
     
    Quote
  3. #3 anonymous, Sep 3, 2016 at 7:35 AM
    anonymous

    anonymous Guest

    you are a schmuck!
     
    Quote
  4. #4 anonymous, Oct 8, 2016 at 9:56 PM
    anonymous

    anonymous Guest

    Oops!!
     
    Quote
  5. #5 anonymous, Oct 21, 2016 at 11:28 PM
    anonymous

    anonymous Guest

    bunch of dumbasses. 3rd line in platinum sensitive? Talk about niched. And you can't even get RR like existing therapies. And how is that pipeline again? Tesaro is going to eat your lunch.
     
    Quote
Reply to Thread